CNBC

Pfizer oral weight loss drug may be as effective as Ozempic injection by Novo Nordisk, study says

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...
Reuters

Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits

CHICAGO, Aug 25 (Reuters) - Pfizer has urged a Florida federal judge to dismiss lawsuits claiming its birth control shot Depo-Provera can cause users to develop a type of brain tumor, saying ...
Nasdaq

Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the ...

Novo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...
Pharmabiz

Pfizer’s Hympavzi receives European approval to treat adults and adolescents with haemophilia A or B with inhibitors

Pfizer’s Hympavzi receives European approval to treat adults and adolescents with haemophilia A or B with inhibitors: New York Thursday, May 14, 2026, 09:00 Hrs [IST] Pfizer Inc ...